TriSalus Life Sciences, Inc. financial data

Symbol
TLSI, TLSIW on Nasdaq
Industry
Surgical & Medical Instruments & Apparatus
Location
6272 West 91 St Avenue, Westminster, CO
State of incorporation
DE
Fiscal year end
December 31
Former names
MedTech Acquisition Corp (to 8/10/2023), MedTech Acquisition Corporation (to 10/29/2020)
Latest financial report
10-Q - Q3 2024 - Nov 14, 2024

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 168 % +88.6%
Quick Ratio 25.3 %
Debt-to-equity -192 % -1090%
Return On Equity 203 % +505%
Return On Assets -216 % -2.99%
Operating Margin -158 %

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 30.5M shares +15.9%
Common Stock, Shares, Outstanding 30.5M shares +15.8%
Entity Public Float 11.6M USD -95.3%
Common Stock, Value, Issued 3K USD +50%
Weighted Average Number of Shares Outstanding, Basic 26.5M shares +101%
Weighted Average Number of Shares Outstanding, Diluted 26.5M shares +101%

Income Statement

Label TTM Value / Value Unit Change %
Revenue from Contract with Customer, Excluding Assessed Tax 26.9M USD +41.5%
Research and Development Expense 22.2M USD -55.6%
Selling and Marketing Expense 24.4M USD +30.9%
General and Administrative Expense 19.3M USD -24.1%
Operating Income (Loss) -42.6M USD +37%
Nonoperating Income (Expense) 3.55M USD -72.5%
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest -55.3M USD +18.7%
Income Tax Expense (Benefit) 8K USD
Net Income (Loss) Attributable to Parent -55.3M USD -19.4%
Earnings Per Share, Basic 28.9 USD/shares +14.3%
Earnings Per Share, Diluted 28.9 USD/shares +14.3%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 11.3M USD -47.2%
Accounts Receivable, after Allowance for Credit Loss, Current 4.91M USD +60.9%
Inventory, Net 4M USD +145%
Assets, Current 23.8M USD -18%
Property, Plant and Equipment, Net 1.82M USD -4.16%
Operating Lease, Right-of-Use Asset 1.43M USD +14%
Other Assets, Noncurrent 424K USD +15.5%
Assets 27.5M USD -18.1%
Accrued Liabilities, Current 7.88M USD +19.3%
Liabilities, Current 9.92M USD +6.59%
Operating Lease, Liability, Noncurrent 1.16M USD
Liabilities 47.9M USD +91.1%
Retained Earnings (Accumulated Deficit) -269M USD -26.6%
Stockholders' Equity Attributable to Parent -20.4M USD -346%
Liabilities and Equity 27.5M USD -18.1%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities -10.9M USD -3.47%
Net Cash Provided by (Used in) Financing Activities 3.13M USD -60.6%
Net Cash Provided by (Used in) Investing Activities -66K USD +10.8%
Common Stock, Shares Authorized 400M shares 0%
Common Stock, Shares, Issued 30.5M shares +15.8%
Common Stock, Par or Stated Value Per Share 0 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect -7.81M USD -195%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 11.6M USD -46.2%
Deferred Tax Assets, Valuation Allowance 51.3M USD +33.8%
Effective Income Tax Rate Reconciliation, at Federal Statutory Income Tax Rate, Percent 0.21 pure 0%
Deferred Tax Assets, Gross 51.8M USD +34.7%
Operating Lease, Liability 1.43M USD
Payments to Acquire Property, Plant, and Equipment 66K USD +843%
Lessee, Operating Lease, Liability, to be Paid 1.9M USD
Operating Lease, Liability, Current 275K USD
Lessee, Operating Lease, Liability, to be Paid, Year Two 205K USD
Lessee, Operating Lease, Liability, to be Paid, Year One 380K USD
Operating Lease, Weighted Average Discount Rate, Percent 0.08 pure
Lessee, Operating Lease, Liability, Undiscounted Excess Amount 470K USD
Lessee, Operating Lease, Liability, to be Paid, Year Three 213K USD
Deferred Tax Assets, Operating Loss Carryforwards 37.3M USD +22.7%
Preferred Stock, Shares Issued 3.99M shares -0.75%
Preferred Stock, Shares Authorized 10M shares 0%
Unrecognized Tax Benefits 0 USD
Lessee, Operating Lease, Liability, to be Paid, Year Four 219K USD
Additional Paid in Capital 249M USD +12.5%
Preferred Stock, Shares Outstanding 3.99M shares -0.75%
Amortization of Intangible Assets 13K USD -40.9%
Interest Expense 887K USD +21825%
Preferred Stock, Par or Stated Value Per Share 0 USD/shares 0%